File Download

There are no files associated with this item.

Supplementary

Conference Paper: Inarigivir demonstrates potent dose dependent anti-viral activity in HBV treatment-naive patients: role of HBeAg status and baseline HBsAg in anti-viral response

TitleInarigivir demonstrates potent dose dependent anti-viral activity in HBV treatment-naive patients: role of HBeAg status and baseline HBsAg in anti-viral response
Authors
Issue Date2018
Citation
Journal of hepatology : the journal of the European Association for the Study of the Liver, v. 68, p. 48A=48A How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/275327

 

DC FieldValueLanguage
dc.contributor.authorYuen, RMF-
dc.contributor.authorElkhashab, M-
dc.contributor.authorChen, CY-
dc.contributor.authoret al, .-
dc.date.accessioned2019-09-10T02:40:19Z-
dc.date.available2019-09-10T02:40:19Z-
dc.date.issued2018-
dc.identifier.citationJournal of hepatology : the journal of the European Association for the Study of the Liver, v. 68, p. 48A=48A-
dc.identifier.urihttp://hdl.handle.net/10722/275327-
dc.languageeng-
dc.relation.ispartofJournal of hepatology : the journal of the European Association for the Study of the Liver-
dc.titleInarigivir demonstrates potent dose dependent anti-viral activity in HBV treatment-naive patients: role of HBeAg status and baseline HBsAg in anti-viral response-
dc.typeConference_Paper-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityYuen, RMF=rp00479-
dc.identifier.hkuros304556-
dc.identifier.volume68-
dc.identifier.spage48A=48A-
dc.identifier.epage48A=48A-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats